Latest Breaking News On - Preliposomal annamycin - Page 1 : comparemela.com

Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic Properties

Annamycin demonstrated to be a more potent inhibitor of topoisomerase II-alpha and II-beta while remaining inactive against established cardiomyocyte cultures.

United statesSan diegoUniversity of texasJenene thomasWalter klempPreliposomal annamycin lyophilizateTrademark officeProperties of annamycinSecurities exchangeAmerican association for cancer researchMoleculin biotech incExchange commissionMoleculin biotechAmerican associationCancer researchAnnual meeting

Moleculin Announces U S Patent Issue Notification for Annamycin Targeting Unmet Need in AML

Moleculin Announces U S Patent Issue Notification for Annamycin Targeting Unmet Need in AML
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of texasJenene thomasPreliposomal annamycin lyophilizateWalter klempUniversity of texas system board regentsPrnewswire moleculin biotech incTrademark officeExchange commissionMoleculin biotech incSecurities exchangeIssue notificationUnited states patentPreliposomal annamycinTexas system boardInstitutional conflict

Moleculin Biotech (MBRX) Issues US Patent for Annamycin Targeting Unmet Need in AML

Moleculin Biotech (MBRX) Issues US Patent for Annamycin Targeting Unmet Need in AML
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPreliposomal annamycin lyophilizateWalter klempMoleculin biotech incUniversity of texas system board regentsTrademark officeMoleculin biotechIssue notificationUnited states patentPreliposomal annamycinTexas system board